|
|
|||
|
|||
| |||
|
|||
| |||
|
|||
| |||
| |||
|
|||
AMCP NEXUS 2019 Street Team: Jann R. Rigell of MedImpact Direct | |||
At AMCP 2019, Jann R. Rigell, RPh, MBA, principal, Enterprise Specialty Programs, MedImpact Direct, shares strategies to rein in specialty drugs costs. | |||
Read More | |||
Preparing for Biosimilar Uptake | |||
As more biosimilar drugs gain approval, managed care organizations need to consider how to best utilize them for optimal savings. | |||
Read More | |||